ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 1785 • ACR Convergence 2022

    PROs and Sociodemographic Factors in Year Prior to COVID Predict Trajectories of Depressive Symptoms in Adults with RA in First 2 Years of Pandemic: Data from the Canadian Early Arthritis Cohort

    Susan Bartlett1, orit schieir2, Marie-France Valois2, Janet Pope3, Louis Bessette4, Gilles Boire5, Carol Hitchon6, Edward Keystone7, Carter Thorne8, Diane Tin9, Glen Hazlewood10 and Vivian Bykerk11, 1McGill University, Montreal, QC, Canada, 2McGill University, Montréal, QC, Canada, 3University of Western Ontario, London, ON, Canada, 4Centre de l'Ostoporose et de Rhumatologie de Québec, Québec, QC, Canada, 5Universite de Sherbrooke, Sherbrooke, QC, Canada, 6University of Manitoba, Winnipeg, MB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8Southlake Regional Health Centre, Newmarket, ON, Canada, 9The Arthritis Program Research Group, Newmarket, ON, Canada, 10University of Calgary, Calgary, AB, Canada, 11Hospital for Special Surgery, New York, NY

    Background/Purpose: Growing evidence points to considerable mental health impacts of the prolonged COVID-19 pandemic, though data from longitudinal studies in rheumatic diseases are sparse. We…
  • Abstract Number: 0201 • ACR Convergence 2022

    Real-World Evidence from Social Media Provides Insights into Patient Mental Health Outcomes in the Management of Gout

    Maurice Flurie1, Joseph Coe2, Monica Converse1, Kristina Davidson3, Colton Flowers1, Kelly Gavigan4, Daniel Hernandez5, Helen Hernandez1, Gary Ho6, Brian LaMoreaux3, Christopher Parker6, E. Robert Wassman1, Christopher DeFelice1 and Maria Picone1, 1TREND Community, Philadelphia, 2Global Healthy Living Foundation, Upper Nyack, 3Horizon Therapeutics, Chicago, IL, 4Global Healthy Living Foundation, Upper Nyack, NY, 5Global Healthy Living Foundation, Nyack, NY, 6Gout Support Group of America, Austin, TX

    Background/Purpose: The ability to actively listen to and interpret the patient experience is vital to effectively address the needs of individuals within a particular community.…
  • Abstract Number: 1908 • ACR Convergence 2022

    Should Osteoarthritis Patients with Pain Scores More Than 8/10 Be Analyzed Separately or Excluded from Clinical Trial Protocols, as 72% Screen Positive for Fibromyalgia And/or Depression on a Multidimensional Health Assessment Questionnaire (MDHAQ)?

    Juan Schmukler1, Kathryn Gibson2, Tengfei Li3, Joel Block1 and Theodore Pincus1, 1Rush University Medical Center, Chicago, IL, 2Liverpool Hospital, Sydney, Australia, 3Georgetown University, Washington, DC

    Background/Purpose: Most osteoarthritis (OA) clinical trial protocols require a 0-10 pain visual numeric scale (VNS) or other quantitative pain score of 4/10 or more for…
  • Abstract Number: 0204 • ACR Convergence 2022

    Persistence of Fatigue, Sleep Disturbance and Mood Disorders in PMR Patients Despite Standard Treatment

    Jessica Leung1, Claire Owen2, David Liew3 and Russell Buchanan3, 1Austin Health, Preston, Victoria, Australia, 2Austin Health, Malvern East, Australia, 3Austin Health, Heidelberg, Australia

    Background/Purpose: Polymyalgia rheumatica (PMR) is typified by pain and stiffness of the shoulder and hip girdles. Previous qualitative studies have highlighted the importance to patients…
  • Abstract Number: 1910 • ACR Convergence 2022

    Evaluation of Dynamic Effects of Depressive Symptoms on Functional Outcomes in Knee Osteoarthritis

    Rhea Mehta1, Marc Hochberg2, Michelle Shardell1, Alice Ryan1, Yu Dong1, Brock Beamer1, Jason Peer2, Megan Schuler3, Joseph Gallo4, Elizabeth Stuart4 and Alan Rathbun1, 1University of Maryland, School of Medicine, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD, 3Rand Inc., Boston, MA, 4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

    Background/Purpose: Knee OA is a leading cause of functional decline, and psychiatric comorbidity is common, particularly major depression. Depressive symptoms decrease physical activity and exacerbate…
  • Abstract Number: 0250 • ACR Convergence 2022

    Performance of Fear Assessment in Inflammatory Rheumatic Diseases (FAIR) Questionnaire in a Cohort of Rheumatoid Arthritis Patients in Argentina

    Jose Simon Alcivar-Navarrete1, Joan Manuel Dapeña1, Juan Manuel Bande1, Eliana Rebeca Serrano1, Maria Alejandra Medina1, Diana Silvia Klajn1, Jose Angel Caracciolo1, Analia Dellepiane2, Maria Paula Kohan3, Maria Julia Sosa3, maria de los angeles correa4, Maximiliano Machado Escobar5, Maria Silvia Yacuzzi5, Debora Guaglianone6, Mariana Benegas7, Emel de Jesus Gonzalez Lobato8, Eduardo Kerzberg8, Sandra Petruzzeli9, Beverly De la Puente Perez10 and Silvia Beatriz Papasidero1, 1Hospital General de Agudos Dr. Enrique Tornu, Buenos Aires, Argentina, 2Centro de Especialidades Medicas Caseros, Casilda, Argentina, 3Hospital Dr. Raul F. Larcade, San Miguel, Buenos Aires, Argentina, 4Rheumatology Unit, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Hospital Eva Peron, Banda del Rio Sali, Argentina, 6Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina, 7Sanatorio Dr. Julio Mendez, Buenos Aires, Argentina, 8Hospital General de Agudos Dr. Ramos Mejia, Buenos Aires, Argentina, 9Casa Hospital San Juan de Dios, Ramos Mejia, Buenos Aires, Argentina, 10Hospital General de Agudos Dr. Jose Maria Penna, Buenos Aires, Argentina

    Background/Purpose: RA is a systemic disease that can compromise many aspects of patient health. The increased psychological burden of RA is known and multifactorial, recent…
  • Abstract Number: 0736 • ACR Convergence 2021

    Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study

    Owen Krystia, Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: While anxiety and depression are highly prevalent in persons with symptomatic knee osteoarthritis (OA), few studies have assessed the effect of treatment of knee…
  • Abstract Number: 0774 • ACR Convergence 2021

    The Impact of Patient/Provider Discordance on Changes on Mood and Behavior in Adolescents with Systemic Lupus Erythematosus

    Zanab Mian1, Terrence Calistro2, Kimberly Rapoza2, Shari Berkowitz2, Tamar Rubinstein3, Kathleen Kenney-Riley2 and Joyce Hui-Yuen4, 1Cohen Children's Medical Center, New Hyde Park, NY, 2Mercy College, Dobbs Ferry, NY, 3Albert Einstein College of Medicine, White Plains, NY, 4Cohen Childrens Medical Center, New Hyde Park, NY

    Background/Purpose: Discordance between physicians’ and patients’ perceptions of disease severity can negatively impact treatment and disease outcomes; this has not yet been studied in children…
  • Abstract Number: 0872 • ACR Convergence 2021

    Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)

    Sudha Raghunath1, Yifat Glikmann-Johnston1, Emma Guymer1, Eric Morand2, Julie Stout1 and Alberta Hoi3, 1Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 3Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia

    Background/Purpose: Cognitive dysfunction (CD) is reported to affect approximately 40% of SLE patients (1). Mood disorders have been associated with both cognitive symptoms and cognitive…
  • Abstract Number: 0878 • ACR Convergence 2021

    Investigating the Neutrophil to Lymphocyte Ratio as a Marker of SLE Disease Activity, Health-Related Quality of Life and Depression

    Eleni Papachristodoulou1, Loukas Kakoullis1, Savvas Psarelis2, Victor Hajiroussos3, Costas Christophi4 and Konstantinos Parperis1, 1University of Cyprus Medical School, Nicosia, Cyprus, 2Nicosia General Hospital/University of Cyprus Medical Schooll, Nicosia, Cyprus, 3Ygia Polyclinic Hospital, Limassol, Cyprus, 4Cyprus University of Technology, Limassol, Cyprus

    Background/Purpose: The need for readily available markers of SLE activity has led to the evaluation of laboratory parameters, such as the neutrophil to lymphocyte ratio…
  • Abstract Number: 0890 • ACR Convergence 2021

    Depression Is Associated with Frailty in Systemic Lupus Erythematosus Patients: Multicenter Retrospective Analysis Using Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index

    Kichul Shin1, In Ah Choi2, Eunyoung Lee3, SE RIM CHOI4, Jina Yeo5, Yun Jong Lee6, Su-Jin Yoo7, Bong-Jin Hahm4, Jee Eun Park4, Ju Ho Lee8, Yeong-Wook Song4 and Ju Yeon Kim4, 1Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Republic of Korea, 2Chungbuk National University Hospital, Cheongju, Republic of Korea, 3Uijeongbu Eulji Medical Center, Seoul, South Korea, 4Seoul National University Hospital, Seoul, Republic of Korea, 5Gil Medical Center, Seoul, South Korea, 6Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea, 7Chungnam National University Hospital, Daejeon, Republic of Korea, 8Seoul National University Bundang Hospital, Yongin Si, Republic of Korea

    Background/Purpose: Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index (SLICC-FI) is a novel health measure in systemic lupus erythematosus (SLE) and was reported to have impact…
  • Abstract Number: 0893 • ACR Convergence 2021

    Trajectories of Depressive Symptoms in Systemic Lupus Erythematosus over 7 Years

    Seerat Chawla1, Jiandong Su2, Zahi Touma3 and Patricia Katz4, 1University of California Los Angeles, Los Angeles, CA, 2University Health Network, Toronto, ON, Canada, 3University of Toronto, Mississauga, ON, Canada, 4University of California San Francisco, San Francisco, CA

    Background/Purpose: Depression remains one of the most frequently observed psychiatric disorders in patients with SLE with a pooled prevalence of 35.0% (95% CI: 29.9%-40.3%). Nevertheless,…
  • Abstract Number: 1059 • ACR Convergence 2021

    The Association of Pain and Sleep in Relation to Depressive Symptoms Among Older Adults with Arthritis

    Uyen-Sa Nguyen1, Cameron Zielke2 and Noah Peeri3, 1University of North Texas Health Science Center, School of Public Health, Arlington, TX, 2University of Illinois-Chicago, Fort Worth, TX, 3University of North Texas Health Science Center, Fort Worth

    Background/Purpose: The primary symptom of arthritis is chronic pain which has widespread consequences on an individual’s sleep and mental health. Research suggests that sleep and…
  • Abstract Number: 1305 • ACR Convergence 2021

    Undiagnosed Depression in Axial Spondyloarthropathy and the Negative Impact on Patient Outcomes: Results of a Screening Study

    Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: Previous research in axial spondyloarthropathy(axSpA) has shown this population to have a high prevalence of depression. This co-morbidity has been previously shown to impact…
  • Abstract Number: 0119 • ACR Convergence 2021

    Worsened Depression but Improved Fatigue Were the Main Impacts of Severe Lockdown in Non- COVID Infected Australian Fibromyalgia Patients

    Benjamin Worcester1, Emma Guymer2 and Geoffrey Littlejohn2, 1Monash Health, Melbourne, Australia, 2Monash University, Melbourne, Australia

    Background/Purpose: To gauge the impact of severe COVID-19 related lockdown restrictions on the mental and physical wellbeing of Australian fibromyalgia patients and their recovery following…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology